AI Discovers a New Biomarker for Sudden Cardiac Death

Sudden cardiac death remains difficult to predict. The current clinical standard — reduced left ventricular ejection fraction (LVEF) — misses most at-risk patients and leads to many unnecessary defibrillator implants.

Researchers used deep learning on a large Swedish dataset of routine ECGs linked to death records and discovered a previously unknown ECG biomarker: a subtle slurred terminal R wave in lead aVL. This pattern is associated with higher risk of sudden cardiac death, likely linked to myocardial fibrosis.

The model significantly outperforms LVEF. It identified a high-risk group with a 7% annual sudden death rate (vs. 4.6% for reduced LVEF patients), and 86% of these high-risk individuals were not flagged by current LVEF criteria. The findings were validated in external datasets from the US and Taiwan.

This Ledger Entry expands how readers think about AI in medicine by showing that deep learning can not only improve prediction but also discover entirely new biomarkers and generate mechanistic hypotheses — in this case identifying a subtle ECG pattern linked to sudden cardiac death risk that was previously unrecognized by human experts.